1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Ophthalmic Diagnostic Equipment Overview

3 Products under Development

• 3.1 Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development
• 3.2 Ophthalmic Diagnostic Equipment - Pipeline Products by Segment
• 3.3 Ophthalmic Diagnostic Equipment - Pipeline Products by Territory
• 3.4 Ophthalmic Diagnostic Equipment - Pipeline Products by Regulatory Path
• 3.5 Ophthalmic Diagnostic Equipment - Pipeline Products by Estimated Approval Date
• 3.6 Ophthalmic Diagnostic Equipment - Ongoing Clinical Trials

4 Ophthalmic Diagnostic Equipment - Pipeline Products under Development by Companies

• 4.1 Ophthalmic Diagnostic Equipment Companies - Pipeline Products by Stage of Development
• 4.2 Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development

5 Ophthalmic Diagnostic Equipment Companies and Product Overview

• 5.1 AcuMEMS Company Overview
• 5.2 Advenio Tecnosys Pvt Ltd Company Overview
• 5.3 Aeon Imaging, LLC Company Overview
• 5.4 Aston EyeTech Ltd Company Overview
• 5.5 Avedro Inc Company Overview
• 5.6 Bar-Ilan University Company Overview
• 5.7 Baylor College of Medicine Company Overview
• 5.8 Beth Israel Deaconess Medical Center Inc Company Overview
• 5.9 Beyeonic Surgical Technologies Company Overview
• 5.10 BioFormatix, Inc. Company Overview
• 5.11 Boston Micromachines Corporation Company Overview
• 5.12 Canon USA Inc Company Overview
• 5.13 Cardiff University Company Overview
• 5.14 Case Western Reserve University Company Overview
• 5.15 CeeMax Ophthalmics Company Overview
• 5.16 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview
• 5.17 ChromoLogic LLC Company Overview
• 5.18 Coland Holdings Limited Company Overview
• 5.19 Compact Imaging Inc. Company Overview
• 5.20 Conavi Medical Inc. Company Overview
• 5.21 Costruzioni Strumenti Oftalmici Cso Srl Company Overview
• 5.22 DigitalVision, LLC Company Overview
• 5.23 Dioptrix Company Overview
• 5.24 Duke University Company Overview
• 5.25 El-Vision Ltd. Company Overview
• 5.26 Epvsensors, LLC Company Overview
• 5.27 Eye Care and Cure Company Overview
• 5.28 eyeMITRA Company Overview
• 5.29 Eyenuk Inc. Company Overview
• 5.30 George Washington University Company Overview
• 5.31 Glakolens Company Overview
• 5.32 Haag-Streit AG Company Overview
• 5.33 Hadasit Medical Research Services and Development Ltd Company Overview
• 5.34 Hadassah Medical Center Company Overview
• 5.35 Heidelberg Engineering GmbH Company Overview
• 5.36 Heriot-Watt University Company Overview
• 5.37 Hong Kong Polytechnic University Company Overview
• 5.38 iHealthScreen Inc Company Overview
• 5.39 I-MED Pharma Inc Company Overview
• 5.40 Imperial College London Company Overview
• 5.41 Implandata Ophthalmic Products GmbH Company Overview
• 5.42 Indian Institute of Technology Bombay Company Overview
• 5.43 i-Optics BV Company Overview
• 5.44 iSonic Medical Company Overview
• 5.45 Johns Hopkins University Company Overview
• 5.46 Kowa Co Ltd Company Overview
• 5.47 LaunchPoint Technologies, Inc. Company Overview
• 5.48 Leica Microsystems GmbH Company Overview
• 5.49 Lumetrics Inc Company Overview
• 5.50 Lygent Inc Company Overview
• 5.51 MacCure Company Overview
• 5.52 Medical University of South Carolina Company Overview
• 5.53 Michigan State University Company Overview
• 5.54 Moorfields Eye Hospital NHS Foundation Trust Company Overview
• 5.55 Nagasaki University Company Overview
• 5.56 National Taiwan University Hospital Company Overview
• 5.57 National University of Ireland Galway Company Overview
• 5.58 Neuro Kinetics Inc Company Overview
• 5.59 nGoggle Inc Company Overview
• 5.60 Nippon Telegraph and Telephone Corp Company Overview
• 5.61 Notal Vision Inc Company Overview
• 5.62 oDocs Eye Care Ltd Company Overview
• 5.63 OptoQuest Company Overview
• 5.64 Optos Plc Company Overview
• 5.65 PAIR Technologies LLC Company Overview
• 5.66 Paradigm Medical Industries, Inc. (Inactive) Company Overview
• 5.67 RetinalGenix, Inc. Company Overview
• 5.68 Retinostics Company Overview
• 5.69 RetinScan Company Overview
• 5.70 Revenio Group Corporation Company Overview
• 5.71 Rice University Company Overview
• 5.72 Rowiak GmbH Company Overview
• 5.73 Rutgers The State University of New Jersey Company Overview
• 5.74 Scalar Bioscience, LLC Company Overview
• 5.75 Sheba Medical Center Company Overview
• 5.76 Sinoora Inc. Company Overview
• 5.77 SOLX Inc Company Overview
• 5.78 Stanford University Company Overview
• 5.79 Stellenbosch University Company Overview
• 5.80 Structured Eye Ltd Company Overview
• 5.81 Tear Diagno LLC (Inactive) Company Overview
• 5.82 The Chinese University of Hong Kong Company Overview
• 5.83 The Wilmer Eye Institute at Johns Hopkins Company Overview
• 5.84 Tissot Medical Research SA Company Overview
• 5.85 TonoGuard Ltd. Company Overview
• 5.86 University of Arizona Company Overview
• 5.87 University of Auckland Company Overview
• 5.88 University of California Berkeley Company Overview
• 5.89 University of California Davis Company Overview
• 5.90 University of California Los Angeles Company Overview
• 5.91 University of California San Diego Company Overview
• 5.92 University of California San Francisco Company Overview
• 5.93 University of Edinburgh Company Overview
• 5.94 University of Illinois at Chicago Company Overview
• 5.95 University of Liverpool Company Overview
• 5.96 University of Malaya Company Overview
• 5.97 University of Pecs Company Overview
• 5.98 University of Pittsburgh Company Overview
• 5.99 University of Rochester Company Overview

5.100 University of South Florida Company Overview

5.101 University of Southern California Company Overview

5.102 University of Texas at Austin Company Overview

5.103 University of Toronto Company Overview

5.104 University of Valencia Company Overview

5.105 University of Washington Company Overview

5.106 VisionQuest Biomedical LLC Company Overview

5.107 Visual Pathways, Inc. (Inactive) Company Overview

5.108 ViVO Smart Medical Devices Ltd Company Overview

5.109 Welch Allyn Inc Company Overview

5.110 Ziemer Ophthalmic Systems AG Company Overview

6 Ophthalmic Diagnostic Equipment- Recent Developments

• 6.1 Jul 09, 2018: MacuLogix Appoints Dr. Amanda K. Lee as Director of Professional Relations
• 6.2 Jul 03, 2018: Carl Zeiss Meditec increases revenue by around 7% in first nine months 2017/18 and adjusts revenue outlook
• 6.3 Jun 27, 2018: Axsun Technologies Reaches Shipment Milestone of 15,000 Swept Lasers for Optical Coherence Tomography Imaging
• 6.4 Jun 27, 2018: UWF imaging could help to monitor disease progression in patients with Alzheimers
• 6.5 Jun 21, 2018: Case Study Using rtx1 Reveals Reduced Photoreceptor Density in Atypical Usher Syndrome
• 6.6 Jun 21, 2018: ISCEV 2018: Presentation on Imaging Cell Loss in Inherited Retinal Disease Using the rtx1
• 6.7 Jun 20, 2018: Improving diagnosis with the latest eye technology
• 6.8 Jun 19, 2018: NIDEK launches the RS-3000 Advance 2 Optical Coherence Tomography
• 6.9 Jun 18, 2018: Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus
• 6.10 Jun 14, 2018: The Core DNA of SPECTRALIS: Upgradable platform
• 6.11 Jun 11, 2018: Optovue Receives FDA Clearance for AngioAnalytics - the World’s First OCT Angiography Metrics
• 6.12 Jun 06, 2018: SyncThink’s EYE-SYNC Named Best New Technology Solution for Monitoring by MedTech Breakthrough Awards
• 6.13 Jun 06, 2018: Study Shows that Adaptive Optics Findings in the Retina might help Prevent Cardiovascular Events
• 6.14 Jun 04, 2018: Leica Microsystems Announces New Market Representation for Southern California Medical Market
• 6.15 Jun 01, 2018: Haag-Streit Unveils the Eyestar 900 Oct Eye Analyser at a Successful RCOphth 2018

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us

Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2019" provides an overview of Ophthalmic Diagnostic Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ophthalmic Diagnostic Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Ophthalmic Diagnostic Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ophthalmic Diagnostic Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ophthalmic Diagnostic Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.